Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion

Afya (NASDAQ:AFYA) Shares Cross Below Two Hundred Day Moving Average - Here's What Happened

Afya logo with Consumer Discretionary background
Image from MarketBeat Media, LLC.

Key Points

Afya Limited (NASDAQ:AFYA - Get Free Report) crossed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $14.31 and traded as low as $10.05. Afya shares last traded at $10.64, with a volume of 1,768,506 shares traded.

Analyst Ratings Changes

A number of analysts recently weighed in on AFYA shares. Bradesco Corretora upgraded Afya to an "outperform" rating and set a $17.00 target price for the company in a research report on Thursday, September 24th. JPMorgan Chase & Co. raised Afya from a "neutral" rating to an "overweight" rating and decreased their price target for the stock from $21.00 to $19.00 in a research note on Wednesday, October 7th. Zacks Research upgraded shares of Afya from a "strong sell" rating to a "hold" rating in a report on Monday, October 5th. Wall Street Zen raised shares of Afya from a "hold" rating to a "buy" rating in a research note on Saturday, September 5th. Finally, Weiss Ratings lowered Afya from a "hold (c)" rating to a "hold (c-)" rating in a research report on Friday, July 31st. Two research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $17.25.

Get Our Latest Analysis on Afya

Afya Stock Performance

The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.20 and a current ratio of 2.20. The business's 50-day moving average is $13.96 and its 200-day moving average is $14.31. The company has a market capitalization of $997.18 million, a PE ratio of 6.49, a PEG ratio of 1.83 and a beta of 0.34.

Afya (NASDAQ:AFYA - Get Free Report) last released its earnings results on Friday, August 14th. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.03. The firm had revenue of $187.80 million during the quarter, compared to analyst estimates of $189.62 million. Afya had a net margin of 20.55% and a return on equity of 17.58%. On average, research analysts anticipate that Afya Limited will post 1.72 earnings per share for the current year.

Insider Transactions at Afya

In other news, insider Santos Welder Ferreira sold 4,161 shares of Afya stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $13.30, for a total value of $55,341.30. Following the completion of the sale, the insider directly owned 35,000 shares in the company, valued at $465,500. The trade was a 10.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Institutional Trading of Afya

A hedge fund recently bought a new stake in Afya stock. Public Employees Retirement System of Ohio bought a new stake in shares of Afya Limited (NASDAQ:AFYA - Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 4,500 shares of the company's stock, valued at approximately $67,000. Hedge funds and other institutional investors own 88.02% of the company's stock.

About Afya

(Get Free Report)

Afya Limited is a medical education and digital health company focused on Brazil. Through its educational platform, the company provides undergraduate medical education, medical residency preparation, specialization and continuing medical education programs, and other learning resources for students and physicians.

Afya also offers digital products and services intended to support healthcare professionals throughout their careers. These include clinical content, study tools, telemedicine and practice-management solutions, and subscription-based applications designed to assist physicians with education, clinical decision-making, and patient care.

The company has expanded through the development and acquisition of medical schools, education businesses, and health technology platforms serving different stages of the medical professional lifecycle.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Afya Right Now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines